CNK-UT-008

N/A

Report date: 2025/05/08 15:04:33

Base Information

Drug NameCNK-UT-008
Drug Alias NameCNK-UT-008
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiabetes Mellitus, Type 1Lupus Erythematosus, SystemicMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesST Phi Therapeutics Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesST Phi Therapeutics Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 1Lupus Erythematosus, SystemicMultiple Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A